# Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS

> **NCT06139744** · PHASE4 · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **DRUG:** DAO supplement
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06139744
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2024-08
- **Final completion:** 2024-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139744, "Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06139744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*